Variables

Covid-19 breakthrough infections in vaccinated people N = 30

Estimated population of gp office N = 2.000

Incidence rates of covid-19 breakthrough infections in vaccinated people x 8 months

= < 14-years

30 (100)

2.000 (100)

1.5 cases per 100 people = < 14-years × 8 months

> = 65-years

8 (27)

349 (17)

2.3 cases per 100 people > = 65- years × 8 months

14-65 years

22 (73)

1651 (83)

1.3 cases per 100 people

14-65 years × 8 months

= < 18-years

0

120 (6)

0

Women

16 (53)

1020 (51)

1.6 cases per 100 women × 8 months

Men

14 (47)

980 (49)

1.4 cases per 100 men × 8 months

BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech)

18 (60)

1380 (69)

1.3 cases per 100 vaccinated × 8 months

mRNA-1273 vaccine (Spikevax, formerly COVID-19 Vaccine Moderna)

1 (3)

260 (13)

0.4 cases per 100 vaccinated × 8 months

ChAdOx1 nCoV-19 vaccine (Vaxzevria, Oxford/AstraZeneca)

6 (20)

260 (13)

2.3 cases per 100 vaccinated × 8 months

Janssen vaccine (Johnson & Johnson vaccine)

5 (17)

100 (5)

5% cases per 100 vaccinated × 8 months